Dendritic Cells Pulsed with Polyomavirus BK Antigen Induce Ex Vivo Polyoma BK Virus-Specific Cytotoxic T-Cell Lines in Seropositive Healthy Individuals and Renal Transplant Recipients

Journal of the American Society of Nephrology

Volumn 14, Issue 12, 2003, Pages 3197-3204

  Comoli, Patrizia ^a   Basso, Sabrina ^a   Azzi, Alberta ^b   Moretta, Antonia ^a   De Santis, Riccardo ^b   Del Galdo, Francesco ^c   De Palma, Raffaele ^c   Valente, Umberto ^d   Nocera, Arcangelo ^d   Perfumo, Francesco ^e   Locatelli, Franco ^a   Maccario, Rita ^a   Ginevri, Fabrizio ^e  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ARTICLE; BK VIRUS; CELL POPULATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NORMAL HUMAN; POLYOMA VIRUS; PREVENTION; PRIORITY JOURNAL; PROBABILITY; RECIPIENT; VIRUS REPLICATION;

EID: 0345098612     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000096374.08473.E3     Document Type: Article

References (44)

1. Chesters PM, Heritage J, McCance DJ: Persistence of DNA sequences of BK virus and JC virus in normal human tissues and diseased tissues. J Infect Dis 147: 676-684, 1983
2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R: Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315: 230-234, 1986
3. Gardner SD, MacKenzie EDF, Smith C, Porter AA: Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 37: 578-586, 1984
4. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH: A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 158: 176-181, 1988
5. Nickeleit V, Hirsch HH, Binet IF, Gudat F, Prince O, Dalquen P, Thiel G, Mihatsch MJ: Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 10: 1080-1089, 1999
6. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH: Testing for Polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342: 1309-1315, 2000
7. Randhawa PS, Demetris AJ: Nephropathy due to polyomavirus type BK. N Engl J Med 342: 1361-1363, 2000
8. Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, Picken MM, Demetris AJ: Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67: 103-109, 1999
9. Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D: Quantitation of BKV virus load in urine and serum and cidofovir therapy for the management of BK virus associated nephropathy in renal transplant recipients. Transplantation 75: 105-112, 2003
10. Rickinson AB, Moss DJ: Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15: 405-431, 1997
11. Thomas JA, Allday MJ, Crawford DH: Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res 57: 329-380, 1991
12. Mejers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153: 478-488, 1986
13. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, O'Reilly RJ: Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N Engl J Med 330: 1185-1191, 1994
14. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241, 1992
15. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345: 9-13, 1995
16. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner KM, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2: 551-555, 1996
17. Comoli P, Labirio M, Basso S, Baldanti F, Grossi P, Furione M, Vigano M, Fiocchi R, Rossi G, Ginevri F, Gridelli B, Moretta A, Montagna D, Locatelli F, Gerna G, Maccario R: Infusion of autologous EBV-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood 99:2592-2598, 2002
18. Ljunggren G, Ljunggren H-G, Dalianis T: T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198:714-716, 1994
19. Luckacher AE, Wilson CS: Resistance to polyoma virus-induced tumors correlates with CTL recognition on an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 160: 1724-1734, 1998
20. Luckacher AE, Moser JM, Hadley A, Altman JD: Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J Immunol 163: 3369-3378, 1999
21. Koralnik IJ, Du Pasquier RA, Letvin NL: JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 75: 3483-3487, 2001
22. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118, 1994
23. Peggs K, Verfuerth S, Mackinnon S: Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: A novel culture system free of live CMV virions. Blood 97: 994-1000, 2001
24. Montagna D, Maccario R, Locatelli F, Rosti V, Yang Y, Farness P, Moretta A, Comoli P, Montini E, Vitiello A: Ex-vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood 98: 3359-3366, 2001
25. Drake DR 3rd, Moser JM, Hadley A, Altman JD, Maliszewski C, Butz E, Lukacher AE: Polyomavirus-infected dendritic cells induce antiviral CD8+ T lymphocytes. J Virol 74: 4093-4101, 2000
26. Pitko VM, Pyökäri P, Näse L, Mäntyjärvi R: Effect of beta-propiolactone on infectivity and haemagglutinin of the BK virus. Acta Pathol Microbiol Scand 83: 141-144, 1975
27. Yang J, Lemas VM, Flinn IW, Krone C, Ambinder RF: Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens. Blood 95: 241-248, 2000
28. Maccario R, Comoli P, Percivalle E, Montagna D, Locatelli F, Gerna G: Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either γδ or αβ T-cell receptor: Role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Immunology 85: 49-56, 1995
29. Bertelli R, Ginevri F, Candiano G, Ciardi MR, Tarelli LT, Meroni M, Sessa A, Ghiggeri GM, Gusmano R: Tubular epithelium culture from nephronophthisis-affected kidneys: A new approach to molecular disorders of tubular cells. Am J Nephrol 10: 463-469, 1990
30. De Palma R, Gorski J: Restricted and conserved T cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci U S A 92: 8836-8840, 1995
31. Bacsi S, De Palma R, Visentin GP, Gorski J, Aster RH: Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/ thrombosis. Blood 94: 208-215, 1999
32. Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, Botti G, Fontana I, Nocera A, Cardillo M, Ciardi MR, Locatelli F, Maccario R, Perfumo F, Azzi A: Polyomavirus BK infection in pediatric kidney allograft recipients: A single center analysis of incidence, risk factors and novel therapeutic approaches. Transplantation 75: 1266-1270, 2003
33. Schluns KS, Lefrancois L: Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3: 269-279, 2003
34. Laky K, Lewis JM, Tigelaar RE, Puddington L: Distinct requirements for IL-7 in development of TCR γδ cells during fetal and adult life. J Immunol 170: 4087-4094, 2003
35. Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM: Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lympho-proliferative disease. Transplantation 73: 1603-1610, 2002
36. Nickeleit V, Hirsch HH, Zeiler M, Gudat F, Prince O, Thiel G, Mihatsch MJ: BK-virus nephropathy in renal transplants-Tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 15: 324-332, 2000
37. Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S: Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 71: 896-899, 2001
38. Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, Schweitzer E, Bartlett ST, Weir MR: Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13: 2145-2151, 2002
39. Johnson RM, Lancki DW, Sperling AI, Dick RF, Spear PG, Fitch FW, Bluestone JA: A murine CD4-, CD8-T cell receptor-gamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein I. J Immunol 148: 983-988, 1992
40. Bukowski JF, Morita CT, Brenner MB: Recognition and destruction of virus-infected cells by human γδ CTL. J Immunol 153: 5133-5140, 1994
41. Sciammas R, Kodukula P, Tang Q, Hendricks RL, Bluestone JA: T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J Exp Med 185: 1969-1975, 1997
42. Lafarge X, Merville P, Cazin MC, Berge F, Potaux L, Moreau JF, Dechanet-Merville J: Cytomegalovirus infection in transplant recipients resolves when circulating γδ T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 184: 533-541, 2001
43. Maccario R, Revello MG, Comoli P, Montagna D, Locatelli F, Gerna G: HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta or alpha/beta human cytotoxic T lymphocytes. J Immunol 150: 1437-1445, 1993
44. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J: Prospective study of polyomavirus type BK and nephropathy in renal transplant recipients. N Engl J Med 347: 488-496, 2002